Search results for: cancer
Inova proton therapy shows survival benefit in landmark phase III trial for head and neck cancer patients
FAIRFAX, VA – A new study published today in The Lancet demonstrates a significant survival benefit for patients with oropharyngeal cancers of the head and neck treated with proton therapy compared with traditional radiation therapy (photon therapy). Inova Schar Cancer and The Mather Proton Therapy Center, home to Northern Virginia’s only proton therapy center and…
Read MorePromising results from the PATHFINDER II cancer screening study
Rebecca Kaltman, MD is a board-certified hematologist oncologist. She serves as the Medical Director of the Inova Saville Cancer Screening and Prevention Center. At Inova Schar Cancer, we’re excited to share encouraging news from a major national research study called PATHFINDER II. This study is helping shape the future of cancer screening – and it’s bringing…
Read MoreInova Schar Cancer Earns international accreditation for stem cell therapy
Fairfax, VA – Inova Schar Cancer has earned internationally-recognized accreditation from the Foundation for the Accreditation of Cellular Therapy (FACT). This accreditation recognizes Inova Schar Cancer’s excellence in delivering safe, high-quality cellular therapies in its cutting-edge program. By demonstrating full compliance with the FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing, and Administration, Inova…
Read MoreEmpowered to outsmart cancer
How one patient turned family history into a healthier future When Wendy Wade’s mother passed away from breast cancer in May 2024, she was left with not just grief but a pressing question: Where could she turn to ensure she was not headed for the same fate? Her mother’s oncologist recommended the Inova Saville Cancer…
Read MoreInova Schar Cancer first in region to deliver Adaptive Online Radiation Therapy
Falls Church, VA – Inova Schar Cancer is proud to announce the rollout of Adaptive Online Radiotherapy – one of the most advanced forms of personalized radiation therapy available today. Inova is the first in the Greater Washington DC area to implement this new technology. Varian Ethos with Hypersight is a cutting-edge radiotherapy solution that…
Read More“Should Runners Be Worried About Colon Cancer?,” Runner’s World, September 19, 2025
While endurance running is widely celebrated for its health benefits, a trailblazing study led by Tim Cannon, MD, Sheridan Director of the Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising link to colon cancer risk. Featured in Runner’s World, the research opens important conversations around screening…
Read MoreWhy subspecialized cancer care matters
John Deeken, MD, is president of the Inova Schar Cancer and Medical Director for the Inova Schar Head and Neck Cancer Program. He is board-certified in medical oncology and specializes in head and neck cancers. When you or someone you love is diagnosed with cancer, one of the most important decisions you face is choosing…
Read MoreGroundbreaking Inova study finds potential link between long-distance running and colon cancer
Fairfax, VA – A groundbreaking new study led by Tim Cannon, MD, Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, has revealed a potential link between extreme endurance exercise and increased risk of advanced colon cancer in younger adults, raising new questions about screening for high-performance athletes.…
Read More“Are Marathons and Extreme Running Linked to Colon Cancer?,” New York Times, August 19, 2025
Running marathons or endurance races is often seen as a hallmark of peak fitness. However, a groundbreaking new study led by Inova oncologist Tim Cannon, MD, Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising prevalence of precancerous colon growths among extreme runners. Recently featured…
Read MoreInova Schar Cancer dosimetry team shines at AAMD International Planning Competition
Historic achievement showcases excellence in proton and photon therapy planning The medical dosimetry team at Inova Schar Cancer has achieved a historic milestone at the 2025 American Association of Medical Dosimetrists (AAMD) International Planning Competition, a globally recognized event showcasing cutting-edge treatment planning expertise. Competing against 194 submissions – 103 from the United States and…
Read More